Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer.

Vilmar A, Santoni-Rugiu E, Cillas JG, Huarriz M, Sørensen JB.

Anticancer Res. 2014 Jun;34(6):2991-6.

PMID:
24922664
2.

Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.

Dziadziuszko R, Merrick DT, Witta SE, Mendoza AD, Szostakiewicz B, Szymanowska A, Rzyman W, Dziadziuszko K, Jassem J, Bunn PA Jr, Varella-Garcia M, Hirsch FR.

J Clin Oncol. 2010 May 1;28(13):2174-80. doi: 10.1200/JCO.2009.24.6611. Epub 2010 Mar 29.

3.

High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.

Gately K, Forde L, Cuffe S, Cummins R, Kay EW, Feuerhake F, O'Byrne KJ.

Clin Lung Cancer. 2014 Jan;15(1):58-66. doi: 10.1016/j.cllc.2013.08.005. Epub 2013 Nov 7.

PMID:
24210543
4.

Clinical significance of IGF1R expression in non-small-cell lung cancer.

Nakagawa M, Uramoto H, Oka S, Chikaishi Y, Iwanami T, Shimokawa H, So T, Hanagiri T, Tanaka F.

Clin Lung Cancer. 2012 Mar;13(2):136-42. doi: 10.1016/j.cllc.2011.10.006. Epub 2011 Dec 1.

PMID:
22133293
5.

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.

Papadaki C, Sfakianaki M, Lagoudaki E, Giagkas G, Ioannidis G, Trypaki M, Tsakalaki E, Voutsina A, Koutsopoulos A, Mavroudis D, Georgoulias V, Souglakos J.

Br J Cancer. 2014 Oct 28;111(9):1757-64. doi: 10.1038/bjc.2014.492. Epub 2014 Sep 18.

6.

Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.

Kim YH, Sumiyoshi S, Hashimoto S, Masago K, Togashi Y, Sakamori Y, Okuda C, Mio T, Mishima M.

Clin Lung Cancer. 2012 Sep;13(5):385-90. doi: 10.1016/j.cllc.2011.11.009. Epub 2012 Jan 28.

PMID:
22285568
7.

Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.

Miura N, Nakamura H, Sato R, Tsukamoto T, Harada T, Takahashi S, Adachi Y, Shomori K, Sano A, Kishimoto Y, Ito H, Hasegawa J, Shiota G.

Cancer Sci. 2006 Dec;97(12):1366-73.

8.
9.

Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.

Agulló-Ortuño MT, Díaz-García CV, Agudo-López A, Pérez C, Cortijo A, Paz-Ares L, López-Ríos F, Pozo F, de Castro J, Cortés-Funes H, López Martín JA.

J Cancer Res Clin Oncol. 2015 Jan;141(1):43-53. doi: 10.1007/s00432-014-1787-z. Epub 2014 Aug 1.

PMID:
25081930
10.

Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer.

Smit EF, Burgers SA, Biesma B, Smit HJ, Eppinga P, Dingemans AM, Joerger M, Schellens JH, Vincent A, van Zandwijk N, Groen HJ.

J Clin Oncol. 2009 Apr 20;27(12):2038-45. doi: 10.1200/JCO.2008.19.1650. Epub 2009 Mar 23.

PMID:
19307503
11.

Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.

Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM.

Anticancer Res. 2009 Apr;29(4):1157-62.

12.

RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy.

Dong S, Guo AL, Chen ZH, Wang Z, Zhang XC, Huang Y, Xie Z, Yan HH, Cheng H, Wu YL.

J Hematol Oncol. 2010 Mar 13;3:10. doi: 10.1186/1756-8722-3-10.

13.

19q13-ERCC1 gene copy number increase in non--small-cell lung cancer.

Vanhecke E, Valent A, Tang X, Vielh P, Friboulet L, Tang T, Goubar A, Li Y, Robin A, Behrens C, Commo F, Validire P, André F, Wistuba II, Soria JC, Olaussen KA.

Clin Lung Cancer. 2013 Sep;14(5):549-57. doi: 10.1016/j.cllc.2013.01.006. Epub 2013 Jun 15.

PMID:
23773262
14.

Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.

Dai CH, Li J, Yu LC, Li XQ, Shi SB, Wu JR.

Tumour Biol. 2013 Apr;34(2):1245-53. doi: 10.1007/s13277-013-0667-5. Epub 2013 Jan 26.

PMID:
23355336
15.

Expression of IGF1R is associated with tumor differentiation and survival in patients with lung adenocarcinoma.

Kikuchi R, Sonobe M, Kobayashi M, Ishikawa M, Kitamura J, Nakayama E, Menju T, Miyahara R, Huang CL, Date H.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S412-20. doi: 10.1245/s10434-011-1878-x. Epub 2011 Jul 6.

PMID:
21732141
16.

Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.

Shimizu K, Yukawa T, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M.

World J Surg Oncol. 2015 Feb 6;13:21. doi: 10.1186/s12957-014-0426-0.

17.

Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer.

Grimminger PP, Schneider PM, Metzger R, Vallböhmer D, Danenberg KD, Danenberg PV, Hölscher AH, Brabender J.

Clin Lung Cancer. 2010 Mar 1;11(2):114-9. doi: 10.3816/CLC.2010.n.015.

PMID:
20199977
18.

Patients treated with platinum-doublet chemotherapy for advanced non--small-cell lung cancer have inferior outcomes if previously treated with platinum-based chemoradiation.

Paramanathan A, Solomon B, Collins M, Franco M, Kofoed S, Francis H, Ball D, Mileshkin L.

Clin Lung Cancer. 2013 Sep;14(5):508-12. doi: 10.1016/j.cllc.2013.03.007. Epub 2013 Jun 20.

PMID:
23792009
19.

Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.

Tang R, Zhong T, Dang Y, Zhang X, Li P, Chen G.

Clin Transl Oncol. 2016 Apr;18(4):360-8. doi: 10.1007/s12094-015-1377-9. Epub 2015 Aug 26.

PMID:
26307752
20.

Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.

Warnecke-Eberz U, Bollschweiler E, Drebber U, Pohl A, Baldus SE, Hoelscher AH, Metzger R.

Oncol Rep. 2008 Sep;20(3):619-24.

PMID:
18695914

Supplemental Content

Support Center